A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS-Associated Cryptococcal Meningitis

Saag, Michael S.; Cloud, Gretchen A.; Graybill, J. Richard; Sobel, Jack D.; Tuazon, Carmelita U.; Johnson, Philip C.; Fessel, W. Jeffrey; Moskovitz, Bruce L.; Wiesinger, Barbara; Cosmatos, Dennis; Riser, Laura; Thomas, Carolynn; Hafner, Richard; Dismukes, William E.
February 1999
Clinical Infectious Diseases;2/1/1999, Vol. 28 Issue 2, p291
Academic Journal
This study was designed to compare the effectiveness of fluconazole vs. itraconazole as mainte-nance therapy for AIDS-associated cryptococcal meningitis. HIV-infected patients who had been successfully treated (achieved negative culture of CSF) for a first episode of cryptococcal meningitis were randomized to receive fluconazole or itraconazole, both at 200 mg/d, for 12 months. The study was stopped prematurely on the recommendation of an independent Data Safety and Monitoring Board. At the time, 13 (23%) of 57 itraconazole recipients had experienced culture-positive relapse, compared with 2 relapses (4%) noted among 51 fluconazole recipients (P = .006). The factor best associated with relapse was the patient having not received flucytosine during the initial 2 weeks of primary treatment for cryptococcal disease (relative risk = 5.88; 95% confidence interval, 1.27-27.14; P = .04). Fluconazole remains the treatment of choice for maintenance therapy for AIDS-associated cryptococcal disease. Flucytosine may contribute to the prevention of relapse if used during the first 2 weeks of primary therapy.


Related Articles

  • Randomized, Double-Blind, Multicenter Trial Comparing Clinafloxacin with Imipenem as Empirical... Winston, Drew J.; Lazarus, Hillard M.; Beveridge, Roy A.; Hathorn, James W.; Gucalp, Rasim; Ramphal, Reuben; Chow, Anthony W.; Ho, Winston G.; Horn, Ruth; Feld, Ronald; Louie, Thomas J.; Territo, Mary C.; Blumer, Jeffrey L.; Tack, Kenneth J. // Clinical Infectious Diseases;2/1/2001, Vol. 32 Issue 3, p381 

    Presents a double-blind, multicenter trial that randomized febrile granulocytopenic patients to receive either intravenous clinafloxacin or imipenem as empirical monotherapy. Level of baseline pathogens susceptible to clinafloxacin than to imipenem; Initial favorable clinical response rates for...

  • Successful Treatment of Vancomycin-Resistant Enterococcus Endocarditis with Oral Linezolid. Babcock, Hilary M.; Starlin, Richard; Little, Russell; Stanley, Sam; Ritchie, David J.; Christiansen, Erin // Clinical Infectious Diseases;5/1/2001, Vol. 32 Issue 9, p1373 

    Discusses the effectiveness of the antimicrobial agent linezolid in treating vancomycin-resistant Enterococcus faecium endocarditis. Information on linezolid; Characteristics of the patient; Results of treatment using chloramphenicol and quinupristin/dalfopristin.

  • Treatment of Gram--Negative Bacillary Meningitis in Adults. Rahal Jr., James J. // Annals of Internal Medicine;Aug72, Vol. 77 Issue 2, p295 

    Provides information on the treatment of Gram-negative bacillary meningitis, associated with the central nervous system. Application of antimicrobial therapy in Gram-negative activity; Utilization of kanamycin and gentamicin as treatment for the condition; Effect of antibiotics on the central...

  • Treatment of Chancroid, 1997. Schmid, George P. // Clinical Infectious Diseases;1/1/1999 Supplement 1, Vol. 28, pS14 

    Evaluates the effectivity of the antimicrobial agents recommended by the United States Centers for Disease Control and Prevention for the treatment of chancroid. High efficacy rates established by azithromycin, ceftriaxone and erythromycin; Increased medication compliance and toleration;...

  • Evaluation of the Potential Nephroprotective and Antimicrobial Effect of Camellia sinensis Leaves versus Hibiscus sabdariffa (In Vivo and In Vitro Studies). Ibrahim, Doa'a Anwar; Albadani, Rowida Noman // Advances in Pharmacological Sciences;2014, p1 

    Green tea and hibiscus are widely consumed as traditional beverages in Yemen and some regional countries. They are relatively cheap and the belief is that they improve health state and cure many diseases. The aim of this study was to evaluate the potential protective and antibacterial activity...

  • Doxycycline Does Not Influence Established Abdominal Aortic Aneurysms in Angiotensin II-Infused Mice. Xiaojie Xie; Hong Lu; Moorleghen, Jessica J.; Howatt, Deborah A.; Rateri, Debra L.; Cassis, Lisa A.; Daugherty, Alan; Qingbo Xu // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Background: There is no proven medical approach to attenuating expansion and rupture of abdominal aortic aneurysms (AAAs). One approach that is currently being investigated is the use of doxycycline. Despite being primarily used as an antimicrobial drug, doxycycline has been proposed to function...

  • Hepatitis C treatment outcomes in Australian clinics. Gidding, Heather F.; Law, Matthew G.; Amin, Janaki; Ostapowics, George; Weltman, Martin; Macdonald, Graeme A.; Sasadeusz, Joe J.; Haber, Paul A. W.; George, Jacob; Dore, Gregory J. // Medical Journal of Australia;6/4/2012, Vol. 196 Issue 10, p633 

    The article discusses a study which evaluated the effectiveness of hepatitis C virus (HCV) treatment in Australian clinics. The recruitment and treatment of patient participants is described. Statistics on sustained virological response (SVR) and human immunodeficiency virus (HIV) coinfection...

  • Issues in the management of bacterial meningitis. Tunkel, Allan R.; Scheld, W. Michael // American Family Physician;10/1/1997, Vol. 56 Issue 5, p1355 

    Presents information on acute bacterial meningitis. Antimicrobial therapies for the disease; Clinical features of patients with acute bacterial meningitis; Diagnostic evaluation of patients with the disease; Initial approach to the management of the disease.

  • CSM UPDATE.  // British Medical Journal (Clinical Research Edition);9/7/1985, Vol. 291 Issue 6496, p665 

    Focuses on the requirements for efficacy and safety of the topical agents for the skin. Evaluation of the drugs by the Committee on Safety of Medicine; Clinical trials of topical dermatological agents; Standard of measurement of physical properties of the skin and risk factors.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics